This case-control study investigates the in vivo imaging of reactive astrocytes and their association with positive symptoms in patients with schizophrenia using validated monoamine oxidase B–binding fluorine 18–labeled THK5351 ([18F]THK5351) positron emission tomography. Here, MAOB is linked to schizophrenia.